Skip to main content
OpenTrials

Clinical trial condition

Grade 3a Follicular Lymphoma

Explore clinical trials studying Grade 3a Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

22 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Grade 3a Follicular Lymphoma trial results

Active, not recruiting

Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma

NCT04450173

Conditions
Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma, +13 more
Locations
  • University of California, San Francisco (UCSF) Fresno Fresno, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California, San Diego San Diego, California, United States
View Trial Details
Completed

Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma

NCT01286272

Conditions
Ann Arbor Stage III Grade 1 Follicular Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, +4 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Saint Helena Hospital St. Helena, California, United States
  • Middlesex Hospital Middletown, Connecticut, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
View all 96 locations
View Trial Details

Related conditions